本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IO Biotech, Inc.

1.49
0.0000
盘后1.41-0.0800-5.37%15:54 EDT
成交量:18.29万
成交额:27.30万
市值:9,816.26万
市盈率:-1.00
高:1.52
开:1.51
低:1.46
收:1.49
数据加载中...
2023/12/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/09/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/06

SEC问询函

Form CORRESP - Correspondence
2023/08/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/16

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/19

重要事件披露

Form 8-K - Current report
2023/06/14

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/20

重要事件披露

8-K - Current report
2023/03/14

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]